MA26980A1 - HISTAMINE RECEPTOR ANTAGONISTS. - Google Patents
HISTAMINE RECEPTOR ANTAGONISTS.Info
- Publication number
- MA26980A1 MA26980A1 MA27233A MA27233A MA26980A1 MA 26980 A1 MA26980 A1 MA 26980A1 MA 27233 A MA27233 A MA 27233A MA 27233 A MA27233 A MA 27233A MA 26980 A1 MA26980 A1 MA 26980A1
- Authority
- MA
- Morocco
- Prior art keywords
- receptor antagonists
- histamine receptor
- histamine
- receptor
- antagonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Antagonistes des récepteurs d'histamine La présente invention propose une association (a) d'un antagoniste des récepteurs d'histamine H1 et (b) d'un antagoniste qui est au moins 10 fois plus sélectif pour le récepteur d'histamine H4 que pour le récepteur d'histamine H3, des compositions la contenant ainsi que leurs utilisations.The present invention provides a combination of (a) a histamine H1 receptor antagonist and (b) an antagonist which is at least 10 times more selective for the histamine H4 receptor than for the histamine H3 receptor, compositions containing it and their uses.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0101223.6A GB0101223D0 (en) | 2001-01-17 | 2001-01-17 | Histamine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA26980A1 true MA26980A1 (en) | 2004-12-20 |
Family
ID=9906993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA27233A MA26980A1 (en) | 2001-01-17 | 2003-07-11 | HISTAMINE RECEPTOR ANTAGONISTS. |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1353657A1 (en) |
| JP (1) | JP2004517883A (en) |
| KR (1) | KR20030069216A (en) |
| CN (1) | CN1486178A (en) |
| AP (1) | AP2002002401A0 (en) |
| AR (1) | AR032101A1 (en) |
| BG (1) | BG107834A (en) |
| BR (1) | BR0206502A (en) |
| CA (1) | CA2435121A1 (en) |
| CR (1) | CR6983A (en) |
| CZ (1) | CZ20031853A3 (en) |
| DO (1) | DOP2002000325A (en) |
| EA (1) | EA200300537A1 (en) |
| EC (1) | ECSP034692A (en) |
| EE (1) | EE200300335A (en) |
| GB (1) | GB0101223D0 (en) |
| GT (1) | GT200200003A (en) |
| HU (1) | HUP0302767A2 (en) |
| IL (1) | IL156087A0 (en) |
| IS (1) | IS6818A (en) |
| MA (1) | MA26980A1 (en) |
| MX (1) | MXPA03006408A (en) |
| NO (1) | NO20033223L (en) |
| OA (1) | OA12440A (en) |
| PA (1) | PA8537101A1 (en) |
| PL (1) | PL362793A1 (en) |
| SK (1) | SK8572003A3 (en) |
| SV (1) | SV2003000849A (en) |
| TN (1) | TNSN02003A1 (en) |
| WO (1) | WO2002056871A2 (en) |
| ZA (1) | ZA200304180B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030133931A1 (en) * | 2001-12-21 | 2003-07-17 | Robin Thurmond | Use of histamine H4 receptor antagonist for the treatment of inflammatory responses |
| MXPA05002577A (en) * | 2002-09-06 | 2005-09-20 | Johnson & Johnson | Use of histamine h4 receptor modulators for the treatment of allergy and asthma. |
| WO2004066960A2 (en) * | 2003-01-28 | 2004-08-12 | Schering Corporation | Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
| US8236786B2 (en) | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| US9688989B2 (en) | 2012-06-08 | 2017-06-27 | Sensorion | H4 receptor inhibitors for treating tinnitus |
-
2001
- 2001-01-17 GB GBGB0101223.6A patent/GB0101223D0/en not_active Ceased
-
2002
- 2002-01-10 HU HU0302767A patent/HUP0302767A2/en unknown
- 2002-01-10 CN CNA028036840A patent/CN1486178A/en active Pending
- 2002-01-10 PL PL02362793A patent/PL362793A1/en not_active Application Discontinuation
- 2002-01-10 WO PCT/IB2002/000042 patent/WO2002056871A2/en not_active Application Discontinuation
- 2002-01-10 BR BR0206502-9A patent/BR0206502A/en not_active IP Right Cessation
- 2002-01-10 JP JP2002557379A patent/JP2004517883A/en not_active Withdrawn
- 2002-01-10 CZ CZ20031853A patent/CZ20031853A3/en unknown
- 2002-01-10 CA CA002435121A patent/CA2435121A1/en not_active Abandoned
- 2002-01-10 IL IL15608702A patent/IL156087A0/en unknown
- 2002-01-10 SK SK857-2003A patent/SK8572003A3/en unknown
- 2002-01-10 EE EEP200300335A patent/EE200300335A/en unknown
- 2002-01-10 KR KR10-2003-7009493A patent/KR20030069216A/en not_active Application Discontinuation
- 2002-01-10 MX MXPA03006408A patent/MXPA03006408A/en unknown
- 2002-01-10 EA EA200300537A patent/EA200300537A1/en unknown
- 2002-01-10 OA OA1200300174A patent/OA12440A/en unknown
- 2002-01-10 EP EP02732099A patent/EP1353657A1/en not_active Withdrawn
- 2002-01-11 DO DO2002000325A patent/DOP2002000325A/en unknown
- 2002-01-14 PA PA20028537101A patent/PA8537101A1/en unknown
- 2002-01-16 AR ARP020100145A patent/AR032101A1/en not_active Application Discontinuation
- 2002-01-16 SV SV2002000849A patent/SV2003000849A/en not_active Application Discontinuation
- 2002-01-16 TN TNTNSN02003A patent/TNSN02003A1/en unknown
- 2002-01-16 GT GT200200003A patent/GT200200003A/en unknown
- 2002-01-17 AP APAP/P/2002/002401A patent/AP2002002401A0/en unknown
-
2003
- 2003-05-15 IS IS6818A patent/IS6818A/en unknown
- 2003-05-21 BG BG107834A patent/BG107834A/en unknown
- 2003-05-22 CR CR6983A patent/CR6983A/en not_active Application Discontinuation
- 2003-05-29 ZA ZA200304180A patent/ZA200304180B/en unknown
- 2003-07-11 MA MA27233A patent/MA26980A1/en unknown
- 2003-07-16 NO NO20033223A patent/NO20033223L/en not_active Application Discontinuation
- 2003-07-17 EC EC2003004692A patent/ECSP034692A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1486178A (en) | 2004-03-31 |
| TNSN02003A1 (en) | 2005-12-23 |
| PA8537101A1 (en) | 2002-08-29 |
| EE200300335A (en) | 2003-12-15 |
| ZA200304180B (en) | 2004-06-15 |
| GT200200003A (en) | 2002-08-19 |
| IL156087A0 (en) | 2003-12-23 |
| PL362793A1 (en) | 2004-11-02 |
| CR6983A (en) | 2003-11-25 |
| GB0101223D0 (en) | 2001-02-28 |
| KR20030069216A (en) | 2003-08-25 |
| NO20033223D0 (en) | 2003-07-16 |
| HUP0302767A2 (en) | 2003-11-28 |
| OA12440A (en) | 2006-05-22 |
| BG107834A (en) | 2004-01-30 |
| NO20033223L (en) | 2003-07-16 |
| CZ20031853A3 (en) | 2004-07-14 |
| JP2004517883A (en) | 2004-06-17 |
| WO2002056871A2 (en) | 2002-07-25 |
| SK8572003A3 (en) | 2004-07-07 |
| BR0206502A (en) | 2003-10-21 |
| IS6818A (en) | 2003-05-15 |
| CA2435121A1 (en) | 2002-07-25 |
| AR032101A1 (en) | 2003-10-22 |
| SV2003000849A (en) | 2003-01-13 |
| EA200300537A1 (en) | 2004-02-26 |
| MXPA03006408A (en) | 2003-10-15 |
| DOP2002000325A (en) | 2003-01-31 |
| AP2002002401A0 (en) | 2002-03-31 |
| ECSP034692A (en) | 2003-08-29 |
| EP1353657A1 (en) | 2003-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tabakowska et al. | Językoznawstwo kognitywne a poetyka przekładu | |
| IL155236A0 (en) | Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity | |
| WO1999048523A3 (en) | Antagonists of the inflammatory mediator oncostatin m (osm) | |
| TNSN06187A1 (en) | SUBSTITUTED ARYLPYRAZOLES AS PARASITICIDES | |
| MXPA04001224A (en) | Agents for enhancing the immune response. | |
| MA28015A1 (en) | CHEMICAL COMPOUNDS | |
| WO2003048207A3 (en) | Anti-dota antibody | |
| MA27921A1 (en) | EMULSIFIING SYSTEMS CONTAINING AZETIDINE DERIVATIVES | |
| MA26980A1 (en) | HISTAMINE RECEPTOR ANTAGONISTS. | |
| DE60138228D1 (en) | METALOTHERMIC REDUCTION OF OXIDES OF FIRE-RESISTANT METALS | |
| ATE266420T1 (en) | COMBINATION PREPARATION CONTAINING SELECTIVE NMDA NR2B ANTAGONISTS AND COX-2 INHIBITORS | |
| FR2863825B1 (en) | CIPC SOLUTIONS AND A TERPENE OR A TERPENIC OIL AND THEIR USES FOR THE TREATMENT OF ANTIGERMINATIVE BULBS OR TUBERS | |
| SE0302370D0 (en) | Delay compositions and detonation delay devices utilizing the same | |
| ATE279923T1 (en) | UROTENSIN-II RECEPTOR ANTAGONISTS | |
| MXPA04002560A (en) | New combination. | |
| DK1546067T3 (en) | The smoke composition | |
| WO2002089740A3 (en) | Sulfonamides | |
| GT199900037A (en) | NEW HERBICIDE COMPOSITIONS. | |
| MA27114A1 (en) | NEW COMBINATION OF AN ANTITHROMBOTIC AND ASPIRIN | |
| FR2791661B1 (en) | NOVEL METAL OXIDE COMPOSITIONS, SEMICONDUCTOR SENSORS PREPARED FROM SUCH A COMPOSITION AND THEIR USES FOR GAS DETECTION. | |
| FR2860436B1 (en) | NEW ASSOCIATION OF ANTI-ATHEROTHROMBOTIC AND AN ANTIAGRAM PLAQUETTAIRE | |
| ATE401257T1 (en) | SINGLE DOSE PACKAGING | |
| ATE346023T1 (en) | MONOLITHICALLY STRUCTURED, BASIC, FIREPROOF CERAMIC HOLLOW BODY | |
| ATE273792T1 (en) | COMPOSITE ELEMENTS CONTAINING BITUMEN | |
| DE50212676D1 (en) | EXOPOLYSACCHARIDPRODUKTION |